Estimating the prevalence of phosphodiesterase-5 inhibitor users bypassing the healthcare system in Europe

被引：0
|
作者：
Kirby, M. [1 ]
Banks, I [2 ]
Zou, K. [3 ]
Schnetzler, G. [4 ]
Symonds, T. [5 ]
机构：
[1] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England
[2] Leeds Metropolitan Univ, Leeds LS1 3HE, W Yorkshire, England
[3] Pfizer Inc, New York, NY USA
[4] Prism Ideas Ltd, Basel, Switzerland
[5] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
来源：
JOURNAL OF SEXUAL MEDICINE | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：416 / 417
页数：2
相关论文
共 50 条
  • [1] THE PREVALENCE OF PHOSPHODIESTERASE-5 INHIBITOR USAGE IN MEN WITH RETROGRADE EJACULATION
    Zhou, C.
    Mumtaz, M.
    Kulla, A.
    Wiseman, B.
    Campbell, K.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [2] Effect of phosphodiesterase-5 inhibitor on hearing
    Okuyucu, S.
    Guven, O. E.
    Akoglu, E.
    Ucar, E.
    Dagli, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (07): : 718 - 722
  • [3] AN INTERNATIONAL COMPARISON OF PHOSPHODIESTERASE-5 INHIBITOR ASSOCIATED MELANOMA
    Mai, K.
    Pham, Q.
    Park, J.
    Kuo, Y.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP149 - NP149
  • [4] The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
    N Mehrotra
    M Gupta
    A Kovar
    B Meibohm
    International Journal of Impotence Research, 2007, 19 : 253 - 264
  • [5] Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension
    Fisher, Jolene H.
    Johnson, Sindhu R.
    BMath, Cathy Chau
    Kron, Amie T.
    Granton, John T.
    CANADIAN RESPIRATORY JOURNAL, 2015, 22 (01) : 42 - 46
  • [6] Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia
    Cantrell, Matthew A.
    Baye, Jordan
    Vouri, Scott Martin
    PHARMACOTHERAPY, 2013, 33 (06): : 639 - 649
  • [7] The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
    Mehrotra, N.
    Gupta, M.
    Kovar, A.
    Meibohm, B.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (03) : 253 - 264
  • [8] Triple kinase inhibitor with phosphodiesterase-5 inhibitor for idiopathic pulmonary fibrosis
    Kishaba, Tomoo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (11) : 5974 - 5978
  • [9] Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine
    Jain, N
    Patil, CS
    Singh, A
    Kulkarni, SK
    PHARMACOLOGY, 2003, 67 (03) : 150 - 156
  • [10] The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size
    Sesti, C.
    Florio, V.
    Johnson, E. G.
    Kloner, R. A.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (01) : 55 - 61
12345